fig2
Figure 2. Overall survival in trials of second-line therapy after progression on sorafenib vs. placebo for advanced hepatocellular carcinoma
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
